A detailed history of Silverarc Capital Management, LLC transactions in Geron Corp stock. As of the latest transaction made, Silverarc Capital Management, LLC holds 1,801,561 shares of GERN stock, worth $7.28 Million. This represents 2.04% of its overall portfolio holdings.

Number of Shares
1,801,561
Previous 999,270 80.29%
Holding current value
$7.28 Million
Previous $4.24 Million 93.08%
% of portfolio
2.04%
Previous 1.2%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.17 - $4.99 $3.35 Million - $4 Million
802,291 Added 80.29%
1,801,561 $8.18 Million
Q2 2024

Aug 14, 2024

BUY
$3.1 - $5.09 $2.32 Million - $3.81 Million
749,270 Added 299.71%
999,270 $4.24 Million
Q1 2024

May 14, 2024

BUY
$1.75 - $3.44 $437,500 - $860,000
250,000 New
250,000 $825,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.53B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.